AUM $232.7MER 0.50%NAV $68.45Holdings 103Inception Dec 2014
Price Chart
Key Statistics
Previous Close
$70.33Day Range
$69.05$70.08
52-Week Range
$34.82$70.79
Avg Volume
43.5KDividend Yield
2.29%Expense Ratio
0.50%AUM
$232.7MShares Outstanding
3.2METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 89.77% |
| Canada | 3.04% |
| United Kingdom | 1.94% |
| Netherlands | 1.59% |
| China | 1.41% |
| Belgium | 1.24% |
| Germany | 0.63% |
| Switzerland | 0.38% |
| Other | 0.00% |
Fund Information
- Issuer
- ALPS Funds
- Category
- Healthcare
- Types
- Healthcare
- Inception Date
- Dec 30, 2014
- Exchange
- NYSE_ARCA
- Description
- The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
Similar ETFs
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $232.7M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 31.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | CRNX | Crinetics Pharmaceuticals Inc. | 4.46% | 122,663 | $10.4M |
| 2 | APGE | Apogee Therapeutics Inc. | 4.17% | 72,063 | $9.7M |
| 3 | CGON | CG oncology Inc. | 3.43% | 102,708 | $8.0M |
| 4 | ORKA | Oruka Therapeutics Inc. | 3.16% | 70,111 | $7.4M |
| 5 | TVTX | Travere Therapeutics Inc. | 3.00% | 108,212 | $7.0M |
| 6 | DNTH | Dianthus Therapeutics Inc. | 2.99% | 63,605 | $7.0M |
| 7 | XENE | Xenon Pharmaceuticals Inc. | 2.89% | 112,414 | $6.7M |
| 8 | ACAD | ACADIA Pharmaceuticals Inc. | 2.49% | 199,183 | $5.8M |
| 9 | DFTX | Definium Therapeutics Inc. | 2.48% | 127,000 | $5.8M |
| 10 | EWTX | Edgewise Therapeutics Inc. | 2.33% | 125,376 | $5.4M |
| 11 | AMLX | Amylyx Pharmaceuticals Inc. | 2.21% | 129,583 | $5.1M |
| 12 | MANE | VeraDermics Inc. | 2.20% | 48,550 | $5.1M |
| 13 | DYN | Dyne Therapeutics Inc. | 2.15% | 192,561 | $5.0M |
| 14 | RLAY | Relay Therapeutics Inc. | 2.14% | 253,377 | $5.0M |
| 15 | DNLI | Denali Therapeutics Inc. | 1.98% | 184,840 | $4.6M |
Page 1 of 3
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.07% | |
| 1W | +0.71% | |
| 1M | +7.91% | |
| 3M | +28.35% | |
| 6M | +34.96% | |
| YTD | +38.72% | |
| 1Y | +98.93% | |
| 3Y | +135.26% | |
| 5Y | +49.15% |
Moving Averages
20-Day MA
$67.12
Above 20-Day MA50-Day MA
$64.60
Above 50-Day MA200-Day MA
$54.64
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$70.79
Current Price
$69.58
52-Week Low
$34.82
$34.82$70.79
Current Yield
2.29%
Annual Dividend
$1.2764
Frequency
1x/year
Last Ex-Date
Dec 19, 2024
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 19, 2024 | $1.1735 | Dec 26, 2024 |
| Dec 21, 2023 | $0.0711 | Dec 27, 2023 |
| Dec 19, 2019 | $0.0160 | Dec 27, 2019 |
| Dec 19, 2019 | $0.0158 | Dec 27, 2019 |
| Dec 20, 2018 | $0.7841 | Dec 27, 2018 |
| Dec 20, 2018 | $0.7840 | Dec 27, 2018 |
| Dec 21, 2017 | $0.5795 | Dec 28, 2017 |
| Dec 21, 2017 | $0.5790 | Dec 28, 2017 |
Dividend Payments Over Time
Category Comparison
| Metric | SBIO | Healthcare(223 ETFs) | Healthcare(24 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.50% | 0.62% | 0.47% |
| AUM | $232.7M | $1.98B | $787.0M |
| Dividend Yield | 2.29% | 3.90% | 1.61% |
| Avg Volume | 43.5K | 422.1K | 74.9K |
| Holdings | 103 | 167 | 170 |
| Performance | |||
| 1-Month Return | +11.00% | +6.56% | +5.58% |
| 6-Month Return | +27.73% | +16.09% | +13.65% |
| YTD Return | +37.31% | +16.75% | +13.64% |
| 1-Year Return | +40.24% | +15.10% | +13.60% |
Compare with Another ETF
Search for an ETF to compare with SBIO:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.